TNF alfa inhibitors

Yusimry 40 mg/0.8 mL single-dose pen Images

Generic Name: adalimumab

This medication has been identified as Yusimry 40 mg/0.8 mL single-dose pen. It is supplied by Coherus BioSciences, Inc.

Yusimry is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Acute; Crohn's Disease, Maintenance; Hidradenitis Suppurativa and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Yusimry 40 mg/0.8 mL single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).

Images

Yusimry (Adalimumab-aqvh)-medicine-40 mg/0.8 mL single-dose pen

Yusimry
Generic Name: adalimumab-aqvh
Imprint: medicine
Strength: 40 mg/0.8 mL single-dose pen
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: TNF alfa inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 70114-0220
Inactive Ingredients:
Latest News
Related Drugs